Verily Life Sciences
Verily Life Sciences Raises $1B in Series D
Quick Facts
Verily Life Sciences Raises $1B in Series D
Verily Life Sciences has successfully raised $1B in a Series D at a $6B valuation led by Temasek, Silver Lake, Ontario Teachers.
Company Overview
Verily Life Sciences is a HealthTech company headquartered in South San Francisco, CA, founded in 2015 with 1500+ employees.
Precision health and life sciences research
Fundraising Details
- Amount Raised: $1B
- Round Type: Series D
- Valuation: $6B
- Date: 2022-01-12
- Investors: Temasek, Silver Lake, Ontario Teachers
About Verily Life Sciences
Precision health and life sciences research The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: South San Francisco, CA
- Founded: 2015
- Team Size: 1500+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Verily Life Sciences's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Verily Life Sciences's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $6B valuation marks an important milestone for Verily Life Sciences, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Verily Life Sciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2022-01-12. For more information about Verily Life Sciences, visit their headquarters at South San Francisco, CA.
About the Author
Related Company Reports
Beacon Software Raises $250M in Series B
Beacon Software, a SaaS company based in San Francisco, CA, has raised $250M in Series B at a $1B valuation led by Riverwood Capital, Norwest Venture Partners.
The Every Company Raises $55M in Series D
The Every Company, a FoodTech company based in San Francisco, CA, has raised $55M in Series D led by Temasek, Section 32, SOSV.
Anrok Raises $55M in Series C
Anrok, a FinTech company based in San Francisco, CA, has raised $55M in Series C led by Sequoia Capital, Index Ventures, Felicis.